Hutchin Hill Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Hutchin Hill Capital’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-31,300	Closed	-$410K	–	1052
2017 Q2	$410K	Buy	31,300 +19,400	+163%	+$256K	0.01%	708
2017 Q1	$156K	Buy	+11,900	New	+$152K	﹤0.01%	865

Other funds holding MYOK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hutchin Hill Capital's MYOK Position: Q3 2017 in Review

Hutchin Hill Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2017, closing a stake of 31,300 shares — an estimated $410K sold.

Hutchin Hill Capital first reported a position in MYOK in Q1 2017 and held it in 2 quarters. The position peaked at $410K in Q2 2017. 115 funds tracked by Wall St. Rank hold MYOK as of Q3 2017.

Hutchin Hill Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Hutchin Hill Capital sold 31,300 MyoKardia, Inc. Common Stock shares in Q3 2017, an estimated $410K.
Hutchin Hill Capital first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
Hutchin Hill Capital's MyoKardia, Inc. Common Stock position peaked at $410K in Q2 2017.
115 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.